Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo upped at Barclays, Avandia concerns overdone
Marketwatch
Friday, June 11, 2010 - 7:59am
tags:
Avandia, diabetes, GSK
Drug Makers Will Share Data From Failed Alzheimer's Trials
WSJ Online
Friday, June 11, 2010 - 7:55am
tags:
Alzheimer's disease, JNJ, GSK, Abbott Laboratories, Sanofi, AstraZeneca
FDA Panel Endorses Novartis Multiple Sclerosis Pill
Pharmalot
Thursday, June 10, 2010 - 8:38pm
tags:
FDA, advisory panels, Novartis, MS, multiple sclerosis, Gilenia
Cardinal acquisition highlights growing specialty drug market
Fierce Pharma
Thursday, June 10, 2010 - 8:37pm
tags:
Cardinal Health, M&A, Healthcare Solutions Holding
700 Lose Their Jobs at Glaxo, But the Lawyers' Jobs Will Be Safe
BNET Pharma
Thursday, June 10, 2010 - 8:33pm
tags:
GSK, layoffs, cafepharma
How Pfizer's Pain Could Be Your Gain
Minyanville
Thursday, June 10, 2010 - 8:31pm
tags:
Pfizer, FDA, warnings
Is The FDA Suppressing An Avandia Study?
Pharmalot
Thursday, June 10, 2010 - 1:05pm
tags:
FDA, GSK, diabetes, Avandia
The Genomics Comeback
Motley Fool
Thursday, June 10, 2010 - 1:04pm
tags:
genomics, Human Genome Sciences, deCODE Genetics
Glaxo buys Argentina firm for $253 million
Marketwatch
Thursday, June 10, 2010 - 1:02pm
tags:
GSK, Argentina, M&A, Laboratorios Phoenix
MannKind Jumps as Inhaled Insulin Shows Superior Data
Barron's
Thursday, June 10, 2010 - 1:00pm
tags:
MannKind, inhaled insulin, Afrezza, diabetes
Abbott Laboratories: Warming Up or Cooling Off?
Motley Fool
Thursday, June 10, 2010 - 12:57pm
tags:
Abbott Laboratories
Glaxo Cuts 700 U.S. Sales and Marketing Positions
WSJ Online
Thursday, June 10, 2010 - 12:18pm
tags:
GSK, layoffs
J&J asks court to toss Omnicare kickback suit
Fierce Pharma
Thursday, June 10, 2010 - 9:48am
tags:
Risperdal, Omnicare, lawsuits, kickbacks, JNJ
Icahn withdraws Genzyme board nominees
FT.com
Thursday, June 10, 2010 - 9:46am
tags:
Carl Icahn, Genzyme
Pharmasset shares rise on positive study results for potential hepatitis C drug
Yahoo/AP
Thursday, June 10, 2010 - 9:45am
tags:
Pharmasset, hepatitis C
Cumberland Pharmaceuticals IPO singled out as worst of past year
Bizjournals.com
Thursday, June 10, 2010 - 9:43am
tags:
IPOs, Cumberland
More to Transcept than Intermezzo
Yahoo/Zacks.com
Thursday, June 10, 2010 - 9:28am
tags:
Intermezzo, Transcept, GSK, insomnia, OCD
Glaxo’s Revolade Fails to Win Recommendation of U.K. Agency
Bloomberg
Thursday, June 10, 2010 - 9:27am
tags:
Revolade, GSK, chronic immune thrombocytopenic purpura
5-Star Stocks Poised to Pop: Johnson & Johnson
Motley Fool
Thursday, June 10, 2010 - 9:24am
tags:
JNJ
FDA warns Pfizer for unreported drug complaints
Yahoo/AP
Thursday, June 10, 2010 - 9:23am
tags:
Pfizer, side effects, FDA, warning

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.